[{"address1": "3963 Maple Avenue", "address2": "Suite 350", "city": "Dallas", "state": "TX", "zip": "75219", "country": "United States", "phone": "972 499 3350", "website": "https://instilbio.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Instil Bio, Inc., a clinical-stage biopharmaceutical company, focuses on developing a pipeline of novel therapies. The company develops cell therapy of tumor infiltrating lymphocyte (TIL) for the treatment of cancer. It is developing early-stage pipeline of CoStAR-TIL and other novel TIL technologies. Instil Bio, Inc. was incorporated in 2018 and is headquartered in Dallas, Texas.", "companyOfficers": [{"maxAge": 1, "name": "Mr. Bronson  Crouch", "age": 51, "title": "Chairman & CEO", "yearBorn": 1973, "fiscalYear": 2023, "totalPay": 1140189, "exercisedValue": 0, "unexercisedValue": 35349}, {"maxAge": 1, "name": "Dr. Sandeep  Laumas M.D.", "age": 55, "title": "CFO & Chief Business Officer", "yearBorn": 1969, "fiscalYear": 2023, "totalPay": 741521, "exercisedValue": 0, "unexercisedValue": 61910}], "auditRisk": 7, "boardRisk": 8, "compensationRisk": 9, "shareHolderRightsRisk": 8, "overallRisk": 8, "governanceEpochDate": 1740787200, "compensationAsOfEpochDate": 1703980800, "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 19.19, "open": 19.13, "dayLow": 18.01, "dayHigh": 20.265, "regularMarketPreviousClose": 19.19, "regularMarketOpen": 19.13, "regularMarketDayLow": 18.01, "regularMarketDayHigh": 20.265, "payoutRatio": 0.0, "forwardPE": -1.5169842, "volume": 78315, "regularMarketVolume": 78315, "averageVolume": 94193, "averageVolume10days": 92790, "averageDailyVolume10Day": 92790, "bid": 14.4, "ask": 23.62, "bidSize": 2, "askSize": 2, "marketCap": 119489040, "fiftyTwoWeekLow": 9.62, "fiftyTwoWeekHigh": 92.0, "fiftyDayAverage": 21.3651, "twoHundredDayAverage": 23.45115, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 83690992, "profitMargins": 0.0, "floatShares": 2670001, "sharesOutstanding": 6525890, "sharesShort": 499941, "sharesShortPriorMonth": 669087, "sharesShortPreviousMonthDate": 1736899200, "dateShortInterest": 1739491200, "sharesPercentSharesOut": 0.0766, "heldPercentInsiders": 0.1282, "heldPercentInstitutions": 0.80386, "shortRatio": 6.32, "shortPercentOfFloat": 0.13260001, "impliedSharesOutstanding": 6525890, "bookValue": 27.023, "priceToBook": 0.67757094, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1735603200, "netIncomeToCommon": -74135000, "trailingEps": -11.39, "forwardEps": -12.07, "lastSplitFactor": "1:20", "lastSplitDate": 1701993600, "enterpriseToEbitda": -1.603, "52WeekChange": 0.64017093, "SandP52WeekChange": 0.121255875, "quoteType": "EQUITY", "currentPrice": 18.31, "targetHighPrice": 180.0, "targetLowPrice": 51.0, "targetMeanPrice": 113.66667, "targetMedianPrice": 110.0, "recommendationMean": 1.75, "recommendationKey": "buy", "numberOfAnalystOpinions": 3, "totalCash": 121143000, "totalCashPerShare": 18.563, "ebitda": -52222668, "totalDebt": 85345000, "debtToEquity": 48.4, "returnOnEquity": -0.36868, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "TIL", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "shortName": "Instil Bio, Inc.", "longName": "Instil Bio, Inc.", "corporateActions": [], "postMarketTime": 1741381595, "regularMarketTime": 1741381200, "esgPopulated": false, "messageBoardId": "finmb_638929728", "exchangeTimezoneName": "America/New_York", "market": "us_market", "marketState": "CLOSED", "regularMarketChangePercent": -4.585727, "regularMarketPrice": 18.31, "exchange": "NCM", "exchangeTimezoneShortName": "EST", "gmtOffSetMilliseconds": -18000000, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1616160600000, "postMarketChangePercent": 0.0, "postMarketPrice": 18.31, "postMarketChange": 0.0, "regularMarketChange": -0.88000107, "regularMarketDayRange": "18.01 - 20.265", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 94193, "fiftyTwoWeekLowChange": 8.69, "fiftyTwoWeekLowChangePercent": 0.9033264, "fiftyTwoWeekRange": "9.62 - 92.0", "fiftyTwoWeekHighChange": -73.69, "fiftyTwoWeekHighChangePercent": -0.8009783, "fiftyTwoWeekChangePercent": 64.01709, "earningsTimestamp": 1741095000, "earningsTimestampStart": 1746707400, "earningsTimestampEnd": 1747053000, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -11.39, "epsForward": -12.07, "epsCurrentYear": -11.51, "priceEpsCurrentYear": -1.5907905, "fiftyDayAverageChange": -3.0551014, "fiftyDayAverageChangePercent": -0.14299494, "twoHundredDayAverageChange": -5.1411514, "twoHundredDayAverageChangePercent": -0.2192281, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2021-03-19", "averageAnalystRating": "1.8 - Buy", "cryptoTradeable": false, "displayName": "Instil Bio", "trailingPegRatio": null, "__fetch_time": "2025-03-08"}]